A Pipeline for Patient Benefit, by Design
Making
Medicines.
Differently.
At insitro, we are building a different kind of drug company to bring better drugs faster to the patients who can benefit most. Through the power of machine learning (ML) and data at scale, we decode the complexities of biology to unlock transformative new medicines.
Scroll for More
Robust Machine Learning Platform, Fueled by Data
insitro’s ML-driven platform integrates in vitro cellular data produced in our labs with human clinical data to help redefine disease. Engineered to accelerate the development of new medicines, our platform precisely identifies therapeutic insights and interventions across a wide spectrum of diseases.
“We set out to create
a unique culture that unites individuals from diverse backgrounds in a single team.”
Daphne Koller
CEO & Founder
A Team Greater Than the Sum of Its Parts
We’ve built a unique culture where life scientists, data scientists, engineers, and drug hunters work together to identify the most important questions, design and scale experiments, build models, and analyze the results. Our differences enhance our strengths, and our collective expertise comes together to generate scientific breakthroughs.
Follow Our Science
Browse our latest news, publications, and speaking engagements to stay informed about our progress in redefining drug discovery and development.
